Kelderman Kim: insider trades.
Kelderman Kim reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.
- Transactions
- 5
- Purchases (P)
- 0
- Sales (S)
- 0
- Companies
- 2
- Name as filed
- Kelderman Kim
Companies
| Company | Relationship | Transactions |
|---|---|---|
| BIO-TECHNE Corp (TECH) | Director, Officer · Chief Executive Officer | 4 |
| CONMED Corp | Director | 1 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-08 | CONMED Corp | M | 500 | $0 | 500 | Form 4 |
| 2026-08-15 | BIO-TECHNE Corp | M | 21,470 | $0 | 93,583 | Form 4 |
| 2026-08-15 | BIO-TECHNE Corp | F | 10,821 | $72.4 | 82,762 | Form 4 |
| 2026-07-28 | BIO-TECHNE Corp | M | 35,000 | $47.6 | 100,799 | Form 4 |
| 2026-07-28 | BIO-TECHNE Corp | F | 28,686 | $72.07 | 72,113 | Form 4 |
Questions
What stock did Kelderman Kim buy or sell?
Kelderman Kim reported 5 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 0 sales, across 2 companies.
Is Kelderman Kim the same person as other filers with this name?
This page covers SEC CIK 1739054 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/kelderman-kim-1739054.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.